[1]
Sikiric, P.; Skrtic, A.; Gojkovic, S.; Krezic, I.; Zizek, H.; Lovric, E.; Sikiric, S.; Knezevic, M.; Strbe, S.; Milavic, M.; Kokot, A.; Boban, B.A.; Seiwerth, S. Gastric pentadecapeptide BPC 157 in cytoprotec-tion to resolve major vessel occlusion disturbances, pringle maneuver and Budd Chiari syndrome. World J. Gastroenterol., 2022, 28, 23-46.
[http://dx.doi.org/10.3748/wjg.v28.i1.23] [PMID: 35125818]
[http://dx.doi.org/10.3748/wjg.v28.i1.23] [PMID: 35125818]
[2]
Seiwerth, S.; Milavic, M.; Vukojevic, J.; Gojkovic, S.; Krezic, I.; Vuletic, L.B.; Pavlov, K.H.; Petrovic, A.; Sikiric, S.; Vranes, H.; Prtoric, A.; Zizek, H.; Durasin, T.; Dobric, I.; Staresinic, M.; Strbe, S.; Knezevic, M.; Sola, M.; Kokot, A.; Sever, M.; Lovric, E.; Skrtic, A.; Blagaic, A.B.; Sikiric, P. Stable gastric pentadecapeptide BPC 157 and wound healing. Front. Pharmacol., 2021, 12, 627533.
[http://dx.doi.org/10.3389/fphar.2021.627533] [PMID: 34267654]
[http://dx.doi.org/10.3389/fphar.2021.627533] [PMID: 34267654]
[3]
Vukojević, J.; Siroglavić, M.; Kašnik, K.; Kralj, T.; Stanćić, D.; Kokot, A.; Kolarić, D.; Drmić, D.; Sev-er, A.Z.; Barišić, I.; Šuran, J.; Bojić, D.; Patrlj, M.H.; Sjekavica, I.; Pavlov, K.H.; Vidović, T.; Vlainić, J.; Stupnišek, M.; Seiwerth, S.; Sikirić, P. Rat Inferior Caval Vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Vascul. Pharmacol., 2018, 106, 54-66.
[http://dx.doi.org/10.1016/j.vph.2018.02.010] [PMID: 29510201]
[http://dx.doi.org/10.1016/j.vph.2018.02.010] [PMID: 29510201]
[4]
Kolovrat, M.; Gojkovic, S.; Krezic, I.; Malekinusic, D.; Vrdoljak, B.; Kovac, K.K.; Kralj, T.; Drmic, D.; Barisic, I.; Pavlov, K.H.; Petrovic, A.; Duzel, A.; Knezevic, M.; Mirkovic, I.; Kokot, A.; Blagaic, A.B.; Seiwerth, S.; Sikiric, P. Pentadecapeptide BPC 157 resolves Pringle Maneuver in rats, both is-chemia and reperfusion. World J. Hepatol., 2020, 12(5), 12-196.
[http://dx.doi.org/10.4254/wjh.v12.i5.184] [PMID: 32547687]
[http://dx.doi.org/10.4254/wjh.v12.i5.184] [PMID: 32547687]
[5]
Duzel, A.; Vlainic, J.; Antunovic, M.; Malekinusic, D.; Vrdoljak, B.; Samara, M.; Gojkovic, S.; Krezic, I.; Vidovic, T.; Bilic, Z.; Knezevic, M.; Sever, M.; Lojo, N.; Kokot, A.; Kolovrat, M.; Drmic, D.; Vukojevic, J.; Kralj, T.; Kasnik, K.; Siroglavic, M.; Seiwerth, S.; Sikiric, P. Stable gastric pentade-capeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J. Gastroenterol., 2017, 23(48), 8465-8488.
[http://dx.doi.org/10.3748/wjg.v23.i48.8465] [PMID: 29358856]
[http://dx.doi.org/10.3748/wjg.v23.i48.8465] [PMID: 29358856]
[6]
Vukojević, J.; Vrdoljak, B.; Malekinušić, D.; Siroglavić, M.; Milavić, M.; Kolenc, D.; Boban Blagaić, A.; Batelja, L.; Drmić, D.; Seiverth, S.; Sikirić, P. The effect of pentadecapeptide BPC 157 on hippo-campal ischemia/reperfusion injuries in rats. Brain Behav., 2020, 10(8), e01726.
[http://dx.doi.org/10.1002/brb3.1726] [PMID: 32558293]
[http://dx.doi.org/10.1002/brb3.1726] [PMID: 32558293]
[7]
Gojkovic, S.; Krezic, I.; Vrdoljak, B.; Malekinusic, D.; Barisic, I.; Petrovic, A.; Pavlov, K.H.; Kolovrat, M.; Duzel, A.; Knezevic, M.; Kovac, K.K.; Drmic, D.; Vuletic, L.B.; Kokot, A.; Blagaic, A.B.; Sei-werth, S.; Sikiric, P. Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-chiari syndrome model in rats. World J. Gastrointest. Pathophysiol., 2020, 11(1), 1-19.
[http://dx.doi.org/10.4291/wjgp.v11.i1.1] [PMID: 32226643]
[http://dx.doi.org/10.4291/wjgp.v11.i1.1] [PMID: 32226643]
[8]
Gojkovic, S.; Krezic, I.; Vranes, H.; Zizek, H.; Drmic, D.; Horvat Pavlov, K.; Petrovic, A.; Batelja Vuletic, L.; Milavic, M.; Sikiric, S.; Stilinovic, I.; Samara, M.; Knezevic, M.; Barisic, I.; Sjekavica, I.; Lovric, E.; Skrtic, A.; Seiwerth, S.; Sikiric, P. BPC 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: Vascular recruitment. Biomedicines, 2021, 9(7), 744.
[http://dx.doi.org/10.3390/biomedicines9070744] [PMID: 34203464]
[http://dx.doi.org/10.3390/biomedicines9070744] [PMID: 34203464]
[9]
Knezevic, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Malekinusic, D.; Vrdoljak, B.; Vranes, H.; Knezevic, T.; Barisic, I.; Horvat Pavlov, K.; Drmic, D.; Staroveski, M.; Djuzel, A.; Rajkovic, Z.; Kolak, T.; Kocman, I.; Lovric, E.; Milavic, M.; Sikiric, S.; Tvrdeic, A.; Patrlj, L.; Strbe, S.; Kokot, A.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Occlusion of the superior mesenteric artery in rats reversed by collateral pathways activation: Gastric pentadecapeptide BPC 157 therapy counteracts multiple or-gan dysfunction syndrome; intracranial, portal and caval hypertension; and aortal hypotension. Biomedicines, 2021, 9(6), 609.
[http://dx.doi.org/10.3390/biomedicines9060609] [PMID: 34073625]
[http://dx.doi.org/10.3390/biomedicines9060609] [PMID: 34073625]
[10]
Knezevic, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Vranes, H.; Malekinusic, D.; Vrdoljak, B.; Knezevic, T.; Horvat Pavlov, K.; Drmic, D.; Staroveski, M.; Djuzel, A.; Rajkovic, Z.; Kolak, T.; Lov-ric, E.; Milavic, M.; Sikiric, S.; Barisic, I.; Tepes, M.; Tvrdeic, A.; Patrlj, L.; Strbe, S.; Sola, M.; Situm, A.; Kokot, A.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Complex syndrome of the complete occlusion of the end of the superior mesenteric vein, opposed with the stable gastric pentadecapeptide BPC 157 in rats. Biomedicines, 2021, 9(8), 1029.
[http://dx.doi.org/10.3390/biomedicines9081029] [PMID: 34440233]
[http://dx.doi.org/10.3390/biomedicines9081029] [PMID: 34440233]
[11]
Knezevic, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Malekinusic, D.; Vrdoljak, B.; Knezevic, T.; Vranes, H.; Drmic, D.; Staroveski, M.; Djuzel, A.; Rajkovic, Z.; Kolak, T.; Lovric, E.; Milavic, M.; Sikiric, S.; Tvrdeic, A.; Patrlj, L.; Strbe, S.; Sola, M.; Situm, A.; Kokot, A.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Occluded superior mesenteric artery and vein. Therapy with the stable gastric pentade-capeptide BPC 157. Biomedicines, 2021, 9(7), 792.
[http://dx.doi.org/10.3390/biomedicines9070792] [PMID: 34356860]
[http://dx.doi.org/10.3390/biomedicines9070792] [PMID: 34356860]
[12]
Kralj, T.; Kokot, A.; Zlatar, M.; Masnec, S.; Kasnik Kovac, K.; Milkovic, P.M.; Batelja Vuletic, L.; Giljanovic, A.; Strbe, S.; Sikiric, S.; Balog, S.; Sontacchi, B.; Sontacchi, D.; Buljan, M.; Lovric, E.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma. Biomedicines, 2021, 10(1), 89.
[http://dx.doi.org/10.3390/biomedicines10010089] [PMID: 35052769]
[http://dx.doi.org/10.3390/biomedicines10010089] [PMID: 35052769]
[13]
Gojkovic, S.; Krezic, I.; Vranes, H.; Zizek, H.; Drmic, D.; Batelja Vuletic, L.; Milavic, M.; Sikiric, S.; Stilinovic, I.; Simeon, P.; Knezevic, M.; Kolak, T.; Tepes, M.; Simonji, K.; Strbe, S.; Nikolac, G.N.; Barisic, I.; Oreskovic, E.G.; Lovric, E.; Kokot, A.; Skrtic, A.; Boban, B.A.; Seiwerth, S.; Sikiric, P. Robert’s intragastric alcohol induced gastric lesion model as an escalated general peripheral and cen-tral syndrome, counteracted by the stable gastric pentadecapeptide BPC 157. Biomedicines, 2021, 9(10), 1300.
[http://dx.doi.org/10.3390/biomedicines9101300] [PMID: 34680419]
[http://dx.doi.org/10.3390/biomedicines9101300] [PMID: 34680419]
[14]
Strbe, S.; Gojkovic, S.; Krezic, I.; Zizek, H.; Vranes, H.; Barisic, I.; Strinic, D.; Orct, T.; Vukojevic, J.; Ilic, S.; Lovric, E.; Muzinic, D.; Kolenc, D.; Filipčić, I.; Zoricic, Z.; Marcinko, D.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Over dose lithium toxicity as an occlusive like syndrome in rats and gastric pentadecapeptide BPC 157. Biomedicines, 2021, 9(11), 1506.
[http://dx.doi.org/10.3390/biomedicines9111506] [PMID: 34829735]
[http://dx.doi.org/10.3390/biomedicines9111506] [PMID: 34829735]
[15]
Tepes, M.; Gojkovic, S.; Krezic, I.; Zizek, H.; Vranes, H.; Madzar, Z.; Santak, G.; Batelja, L.; Milavic, M.; Sikiric, S.; Kocman, I.; Simonji, K.; Samara, M.; Knezevic, M.; Barisic, I.; Lovric, E.; Strbe, S.; Kokot, A.; Sjekavica, I.; Kolak, T.; Skrtic, A.; Seiwerth, S.; Boban, B.A.; Sikiric, P. Stable gastric pentadecapeptide BPC 157 therapy for primary abdominal compartment syndrome in rats. Front. Pharmacol., 2021, 12, 718147.
[http://dx.doi.org/10.3389/fphar.2021.718147] [PMID: 34966273]
[http://dx.doi.org/10.3389/fphar.2021.718147] [PMID: 34966273]
[16]
Smoday, I.M.; Petrovic, I.; Kalogjera, L.; Vranes, H.; Zizek, H.; Krezic, I.; Gojkovic, S.; Skorak, I.; Hriberski, K.; Brizic, I.; Kubat, M.; Strbe, S.; Barisic, I.; Sola, M.; Lovric, E.; Lozic, M.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Therapy effect of the stable gastric pentadecapeptide BPC 157 on acute pancreatitis as vascular failure induced severe peripheral and central syndrome in rats. Biomedicines, 2022, 10(6), 1299.
[http://dx.doi.org/10.3390/biomedicines10061299] [PMID: 35740321]
[http://dx.doi.org/10.3390/biomedicines10061299] [PMID: 35740321]
[17]
Barisic, I.; Balenovic, D.; Udovicic, M.; Bardak, D.; Strinic, D.; Vlainić, J.; Vranes, H.; Smoday, I.M.; Krezic, I.; Milavic, M.; Sikiric, S.; Uzun, S.; Zivanovic Posilovic, G.; Strbe, S.; Vukoja, I.; Lovric, E.; Lozic, M.; Sever, M.; Lovric Bencic, M.; Boban, B.A.; Skrtic, A.; Seiwerth, S.; Sikiric, P. Stable gas-tric pentadecapeptide BPC 157 may counteract myocardial infarction induced by isoprenaline in rats. Biomedicines, 2022, 10(2), 265.
[http://dx.doi.org/10.3390/biomedicines10020265] [PMID: 35203478]
[http://dx.doi.org/10.3390/biomedicines10020265] [PMID: 35203478]
[18]
Robert, A. Cytoprotection by prostaglandins. Gastroenterology, 1979, 77(4), 761-767.
[http://dx.doi.org/10.1016/0016-5085(79)90235-X] [PMID: 38173]
[http://dx.doi.org/10.1016/0016-5085(79)90235-X] [PMID: 38173]
[19]
Szabo, S.; Trier, J.S.; Brown, A.; Schnoor, J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology, 1985, 88(1), 228-236.
[http://dx.doi.org/10.1016/S0016-5085(85)80176-1] [PMID: 3871087]
[http://dx.doi.org/10.1016/S0016-5085(85)80176-1] [PMID: 3871087]
[20]
Masnec, S.; Kokot, A.; Zlatar, M.; Kalauz, M.; Kunjko, K.; Radic, B.; Klicek, R.; Drmic, D.; Lazic, R.; Brcic, L.; Radic, R.; Ivekovic, R.; Seiwerth, S.; Sikiric, P. Perforating corneal injury in rat and pen-tadecapeptide BPC 157. Exp. Eye Res., 2015, 136, 9-15.
[http://dx.doi.org/10.1016/j.exer.2015.04.016] [PMID: 25912999]
[http://dx.doi.org/10.1016/j.exer.2015.04.016] [PMID: 25912999]
[21]
Sikiric, P.; Seiwerth, S.; Rucman, R.; Turkovic, B.; Rokotov, D.; Brcic, L.; Sever, M.; Klicek, R.; Radic, B.; Drmic, D.; Ilic, S.; Kolenc, D.; Aralica, G.; Stupnisek, M.; Suran, J.; Barisic, I.; Dzidic, S.; Vrcic, H.; Sebecic, B. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr. Pharm. Des., 2014, 20(7), 1126-1135.
[http://dx.doi.org/10.2174/13816128113190990411] [PMID: 23755725]
[http://dx.doi.org/10.2174/13816128113190990411] [PMID: 23755725]
[22]
Stupnisek, M.; Kokot, A.; Drmic, D.; Hrelec Patrlj, M.; Zenko Sever, A.; Kolenc, D.; Radic, B.; Su-ran, J.; Bojic, D.; Vcev, A.; Seiwerth, S.; Sikiric, P. Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin, L-NAME and L-arginine. PLoS One, 2015, 10(4), e0123454.
[http://dx.doi.org/10.1371/journal.pone.0123454] [PMID: 25897838]
[http://dx.doi.org/10.1371/journal.pone.0123454] [PMID: 25897838]
[23]
Konosic, S.; Petricevic, M.; Ivancan, V.; Konosic, L.; Goluza, E.; Krtalic, B.; Drmic, D.; Stupnisek, M.; Seiwerth, S.; Sikiric, P. Intragastric application of aspirin, clopidogrel, cilostazol, and BPC 157 in rats: Platelet aggregation and blood clot. Oxid. Med. Cell. Longev., 2019, 2019, 9084643.
[http://dx.doi.org/10.1155/2019/9084643] [PMID: 31976029]
[http://dx.doi.org/10.1155/2019/9084643] [PMID: 31976029]
[24]
Hsieh, M.J.; Liu, H.T.; Wang, C.N.; Huang, H.Y.; Lin, Y.; Ko, Y.S.; Wang, J.S.; Chang, V.H.S.; Pang, J.H.S. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J. Mol. Med., 2017, 95(3), 323-333.
[http://dx.doi.org/10.1007/s00109-016-1488-y] [PMID: 27847966]
[http://dx.doi.org/10.1007/s00109-016-1488-y] [PMID: 27847966]
[25]
Hsieh, M.J.; Lee, C.H.; Chueh, H.Y.; Chang, G.J.; Huang, H.Y.; Lin, Y.; Pang, J.H.S. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci. Rep., 2020, 10(1), 17078.
[http://dx.doi.org/10.1038/s41598-020-74022-y] [PMID: 33051481]
[http://dx.doi.org/10.1038/s41598-020-74022-y] [PMID: 33051481]
[26]
Zlatar, M.; Kokot, A.; Vuletic, L.B.; Masnec, S.; Kralj, T.; Perisa, M.M.; Barisic, I.; Radic, B.; Mila-novic, K.; Drmic, D.; Seiwerth, S.; Sikiric, P.; Zlatar, M.; Sikiric, P.; Masnec, S. BPC 157 as a therapy for retinal ischemia induced by retrobulbar application of L-NAME in rats. Front. Pharmacol., 2021, 12, 632295.
[http://dx.doi.org/10.3389/fphar.2021.632295] [PMID: 34177567]
[http://dx.doi.org/10.3389/fphar.2021.632295] [PMID: 34177567]
[27]
Sikiric, P.; Seiwerth, S.; Rucman, R.; Turkovic, B.; Rokotov, D.S.; Brcic, L.; Sever, M.; Klicek, R.; Radic, B.; Drmic, D.; Ilic, S.; Kolenc, D.; Aralica, G.; Safic, H.; Suran, J.; Rak, D.; Dzidic, S.; Vrcic, H.; Sebecic, B. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr. Pharm. Des., 2013, 19(1), 76-83.
[PMID: 22950504]
[PMID: 22950504]
[28]
Park, J.M.; Lee, H.J.; Sikiric, P.; Hahm, K.B. BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection. Curr. Pharm. Des., 2020, 26(25), 2971-2981.
[http://dx.doi.org/10.2174/1381612826666200523180301] [PMID: 32445447]
[http://dx.doi.org/10.2174/1381612826666200523180301] [PMID: 32445447]
[29]
Seiwerth, S.; Rucman, R.; Turkovic, B.; Sever, M.; Klicek, R.; Radic, B.; Drmic, D.; Stupnisek, M.; Misic, M.; Vuletic, L.B.; Pavlov, K.H.; Barisic, I.; Kokot, A.; Japjec, M.; Blagaic, A.B.; Tvrdeic, A.; Rokotov, D.S.; Vrcic, H.; Staresinic, M.; Sebecic, B.; Sikiric, P. BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr. Pharm. Des., 2018, 24(18), 1972-1989.
[http://dx.doi.org/10.2174/1381612824666180712110447] [PMID: 29998800]
[http://dx.doi.org/10.2174/1381612824666180712110447] [PMID: 29998800]
[30]
Deek, S.A. BPC 157 as potential treatment for COVID-19. Med. Hypotheses, 2022, 158, 110736.
[http://dx.doi.org/10.1016/j.mehy.2021.110736] [PMID: 34798584]
[http://dx.doi.org/10.1016/j.mehy.2021.110736] [PMID: 34798584]
[31]
Kang, E.A.; Han, Y.M.; An, J.M.; Park, Y.J.; Sikiric, P.; Kim, D.H.; Kwon, K.A.; Kim, Y.J.; Yang, D.; Tchah, H.; Hahm, K.B. BPC157 as potential agent rescuing from cancer cachexia. Curr. Pharm. Des., 2018, 24(18), 1947-1956.
[http://dx.doi.org/10.2174/1381612824666180614082950] [PMID: 29898649]
[http://dx.doi.org/10.2174/1381612824666180614082950] [PMID: 29898649]
[32]
Xu, C.; Sun, L.; Ren, F.; Huang, P.; Tian, Z.; Cui, J.; Zhang, W.; Wang, S.; Zhang, K.; He, L.; Zhang, W.; Zhang, C.; Hao, Q.; Zhang, Y.; Li, M.; Li, W. Preclinical safety evaluation of body protective compound 157, a potential drug for treating various wounds. Regul. Toxicol. Pharmacol., 2020, 114, 104665.
[http://dx.doi.org/10.1016/j.yrtph.2020.104665] [PMID: 32334036]
[http://dx.doi.org/10.1016/j.yrtph.2020.104665] [PMID: 32334036]